Kailera Therapeutics, Inc. · NASDAQ:KLRA

Renaud Ronald C JR exercised options for 38,094 Kailera Therapeutics, Inc. shares (Form 4)

Traded Jun 9, 2026 · Filed Jun 11, 2026

On Jun 9, 2026, Renaud Ronald C JR (Director, CEO & President) exercised options for 38,094 Kailera Therapeutics, Inc. shares at US$5.25 for US$200K, leaving 38,094 shares. Filed Jun 11, 2026 (Form 4).

Options exercised
38,094 shares
Price
US$5.25
Value
US$200K
Holding after
38,094 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 9, 2026Common StockOption exercise38,094US$5.2538,094Direct

Source

View original at SEC

Related